The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of a tailored exercise intervention during or after chemotherapy on cardiovascular morbidity in cancer patients.
 
Gabriela G.F. Giovanna Femma van der Schoot
No Relationships to Disclose
 
Harm Laurens Ormel
No Relationships to Disclose
 
Nico-Derk L. Westerink
No Relationships to Disclose
 
Annette Van Der Velden
Travel, Accommodations, Expenses - MSD (Inst); Roche (Inst)
 
Boelo Jan Poppema
No Relationships to Disclose
 
Rudolf Stephan Nicolaas Fehrmann
No Relationships to Disclose
 
Joop D. Lefrandt
Consulting or Advisory Role - Amgen (Inst); Sanofi (Inst)
 
Arie M. van Roon
No Relationships to Disclose
 
Joost van Melle
No Relationships to Disclose
 
Peter Van der Meer
Consulting or Advisory Role - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); SERVIER (Inst); Vifor Pharma (Inst)
Speakers' Bureau - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); SERVIER (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst); Ions Pharmaceuticals (Inst); Pfizer (Inst); Vifor Pharma (Inst)
 
Johan B. Wempe
No Relationships to Disclose
 
Marcel ten Wolde
No Relationships to Disclose
 
Joyce Stel
No Relationships to Disclose
 
Aline H. Vrieling
No Relationships to Disclose
 
Niek de Boer
No Relationships to Disclose
 
Anne Maria May
Consulting or Advisory Role - Novartis (Inst)
 
Sjoerd G. Elias
No Relationships to Disclose
 
Jourik A. Gietema
Research Funding - Abbvie (Inst); Roche/Genentech (Inst); Siemens (Inst)
 
Anna Maria Elisabeth Walenkamp
Consulting or Advisory Role - Ipsen (Inst); Karyopharm Therapeutics (Inst); Polyphor (Inst)
Research Funding - Ipsen (Inst); Novartis (Inst)